BAY 1902607: Single Dose Escalation, Safety and Tolerability, Pharmacokinetics, Bioavailability, Food Effect

NCT03212586 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Clinical Trials, Phase I as Topic

Interventions

DRUG: BAY1902607
DRUG: Placebo

Sponsor

Bayer